Connect with the Leaders Shaping Molecular Glue Innovation
With increasing investment, major licensing deals, clinical validation, and growing interest in induced proximity therapeutics, organisations are actively seeking technologies and expertise that can accelerate molecular glue discovery and development. The 5th Molecular Glue Drug Development Summit brings together the scientists and decision-makers driving this rapidly evolving field, creating a unique environment to:
- Showcase your capabilities to organisations actively investing in molecular glue therapeutics
- Build strategic partnerships across pharma, biotech, academia, and investment
- Generate qualified business opportunities with teams seeking innovative platforms and services
- Understand evolving scientific priorities around AI, structural biology, proteomics, screening, chemistry, and translational development
- Position your brand at the forefront of induced proximity drug discovery
What to Expect?
Forge Strategic Partnerships
Build relationships with the scientists, drug developers, and business leaders shaping the future of molecular glue therapeutics.
Demonstrate Your Innovation
Showcase how your platform, service, or technology helps solve key challenges in target identification, rational design, protein degradation, stabilization, and translational development.
Uncover Emerging Opportunities
Hear directly from leaders advancing AI-enabled discovery, proximity pharmacology, E3 ligase biology, and novel therapeutic mechanisms.
Maximize Brand Recognition
Strengthen your market presence through premium speaking, exhibition, branding, and networking opportunities.
Key Services & Solutions
Our attendees are looking for service and solution providers with capabilities in the areas below and beyond:
Discovery & Screening
Innovative screening platforms, assay technologies, and hit-identification approaches enabling efficient molecular glue discovery.
Proteomics & Chemoproteomics
Proteomic technologies to validate targets, identify substrates, characterize mechanisms, and understand induced proximity biology.
Structural Biology & Protein Analysis
Biophysics, cryo-EM, structural biology, and protein characterization technologies supporting rational molecular design.
Computational Drug Discovery & AI
Machine learning, generative chemistry, structure prediction, bioinformatics, and computational modelling technologies accelerating molecular glue discovery.
Medicinal Chemistry
Molecular optimisation, structure-activity relationship studies, and chemical biology expertise to improve potency, selectivity, and developability.
Synthesis Services
Custom synthesis, compound libraries, and chemistry support for discovery and preclinical programmes.
Translational & Preclinical Development
Biomarkers, PK/PD, efficacy models, toxicology, and translational strategies supporting progression toward the clinic.
Integrated Drug Discovery Services
End-to-end CRO and discovery partnerships supporting programmes from target validation through IND-enabling studies.
Audience Composition
Attending Companies
Available Inventory
From thought-leadership opportunities to bespoke networking experiences, we offer a range of sponsorship packages designed to connect you with key decision-makers across the molecular glue ecosystem.
Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.
Samuel Turner
Partnerships Director
Stay Ahead of the Science
Position your organisation at the centre of breakthroughs in molecular glue therapeutics and induced proximity biology.
Meet Key Decision-Makers
Connect with pharma, biotech, academic, and investment leaders actively advancing the next generation of medicines.
Showcase Your Innovation
Build a tailored sponsorship package featuring speaking, exhibiting, branding, and networking opportunities.